These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8466235)

  • 1. An update on Laron syndrome.
    Laron Z
    Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
    [No Abstract]   [Full Text] [Related]  

  • 2. The chronicle of growth hormone receptor deficiency (Laron syndrome).
    Rosenbloom AL
    Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
    [No Abstract]   [Full Text] [Related]  

  • 3. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
    Laron Z
    J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular defects in the growth hormone receptor.
    Amselem S; Duquesnoy P; Sobrier ML; Goossens M
    Acta Paediatr Scand Suppl; 1991; 377():81-6. PubMed ID: 1785318
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
    Laron Z; Klinger B; Erster B; Anin S
    Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z; Klinger B; Jensen LT; Erster B
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.
    Godowski PJ; Leung DW; Meacham LR; Galgani JP; Hellmiss R; Keret R; Rotwein PS; Parks JS; Laron Z; Wood WI
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8083-7. PubMed ID: 2813379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of growth hormone resistance in childhood.
    Laron Z
    Curr Opin Pediatr; 1993 Aug; 5(4):474-80. PubMed ID: 8374676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
    Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
    N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue.
    Walker JL; Crock PA; Behncken SN; Rowlinson SW; Nicholson LM; Boulton TJ; Waters MJ
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2554-61. PubMed ID: 9661642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
    Gluckman PD; Ambler GR
    Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular genetics of Laron-type GH insensitivity syndrome.
    Goossens M; Amselem S; Duquesnoy P; Sobrier ML
    Recent Prog Horm Res; 1993; 48():165-78. PubMed ID: 8441847
    [No Abstract]   [Full Text] [Related]  

  • 18. Laron syndrome - A historical perspective.
    Laron Z; Werner H
    Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth hormone receptor and dwarfism].
    Postel-Vinay MC
    Rev Prat; 1994 May; 44(10):1281-5. PubMed ID: 7939185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone-receptor gene in Laron dwarfism.
    Bass S; Wells J
    N Engl J Med; 1990 Mar; 322(12):854-5. PubMed ID: 2308623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.